ArticleJournal of vascular surgery cases and innovative techniques2025
Endovascular repair of ascending aortic pseudoaneurysms using the GORE TAG Thoracic Branch Endoprosthesis Proximal Extender.
Article in Journal of vascular surgery cases and innovative techniques, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Transaxillary endovascular repair of a mycotic ascending aortic pseudoaneurysm using a rifampin-soaked Dacron-based Cook Zenith Flex abdominal aortic cuff.Journal of vascular surgery cases and innovative techniques · 2026Article
- Best of 2025-Thoracic and thoracoabdominal aneurysms and dissections.Journal of vascular surgery cases and innovative techniques · 2026Article
- Ascending, arch, and cerebrovascular disease: Best of 2025 in theJournal of vascular surgery cases and innovative techniques · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ascending aortic pseudoaneurysms (AAPs) are a rare but morbid complication after cardiac surgery. Although the mainstay of AAP treatment is open surgery, endovascular repair can be considered for high-risk surgical candidates with suitable anatomy. With no US Food and Drug Administration-approved devices for the treatment of zone 0 pathology, endovascular repair of AAP is being performed with off-label use of available devices. Here we present two cases of successful AAP exclusion using the GORE TAG Thoracic Branch Endoprosthesis Aortic Extender.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.